FDA Investigator Sereen Gmorgan Murray

Sereen Gmorgan Murray has conducted inspections on 71 sites in 4 countries as of 18 Oct 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
71
Last Inspection Date:
18 Oct 2021
Investigator Role:
FDA Investigator
Redica ID:
100008149
Countries of Inspections:
United States of America, Hungary, Korea (Republic of), New Zealand
FDA Investigators that have inspected at least one site in common with Sereen Gmorgan Murray:
Alan R Moore, Ann B Borromeo, Anne E Johnson, Anthony S Puckett, April R Bowen, Arlyss M Jones, Barbara M Frazier, Betsy C Galliher, Bonita S Chester, Brandy D Brown, Cheryl A Grandinetti, Christopher M Jeffers, Claudele S Razo, Craig A Garmendia, Cynthia F Kleppinger, MD, David T Glover, Dawn C Olenjack, Derek C Price, Devaughn Edwards, Dr. Koffi A Amegadje, Edward Deberry, Eileen J Bannerman, Ernest H Blackwood, Ingrid A Zambrana, Jackie M Douglas, Jawaid Hamid, John D Lloyd, Joseph F Owens, Karen M Cooper, Kassa Ayalew, MD, Kent A Conforti, Lareese K Thomas, Laura L Staples, Lawrence Thomas, Leah M Andrews, Leon L Crawley, Marshall A Naimo, Matthew R Coleman, Michelle D Haamid, Michelle M Noe Varga, Myla D Chapman, N'jere English, Nicole M Bell, Patricia S Smith, Sandra I Gaul, Sheri S Oliver, Stephanie E Hubbard, Tracy R Ball, Tyrico K English, Vanessa E Coulter, Viviana Matta, William P Tonkins

Sereen Gmorgan Murray's Documents

Publish Date Document Type Title
April, 2016 FDA 483 J. David Lentz III, M.D. - Form 483, 2016-04-25
October, 2019 FDA 483 Kennedy, Philip R. - Form 483, 2019-10-16
August, 2016 EIR Martin Throne MD - EIR, 2016-08-05
March, 2016 EIR Phoebe Putney Mem Hosp Irc - EIR, 2016-03-03
November, 2017 FDA 483 O'Barr, Thomas MD - Form 483, 2017-11-30
October, 2018 FDA 483 Naomi Akita, MD - Form 483, 2018-10-11
October, 2016 EIR Sagar Lonial, M.D. - EIR, 2016-10-28
November, 2021 FDA 483 Daniel C. Tarquinio, DO - Form 483, 2021-11-05
May, 2021 EIR PPD, Inc., part of Thermo Fisher Scientific - EIR, 2021-05-21
September, 2019 FDA 483 Laura Mulloy, D.O. - Form 483, 2019-09-11
February, 2018 FDA 483 Wellstar Atlanta Medical Center IRB#1 - Form 483, 2018-02-15
March, 2017 FDA 483 Robert Donald Harvey - Form 483, 2017-03-24
April, 2018 FDA 483 Theresa Lawrence Ford - Form 483, 2018-04-03
March, 2018 FDA 483 Georgia STE DEPT Human Resources IRB#1 - Form 483, 2018-03-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more